The effect of fibrate–statin combination therapy on cardiovascular events: a retrospective cohort analysis

By Wierzbicki Anthony S.   Morrell Jonathan   Hemsley Deborah   McMahon Zofia   Crook Martin A.   Wray Richard  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2141-2146

Informa Healthcare

Access to resources Recommend Favorite

Rhabdomyolysis and Acute Renal Failure after Changing Statin-Fibrate Combinations

By  

Cardiology, Vol. 94, Iss. 2, 2001-01 ,pp. : 127-128

Karger

Access to resources Recommend Favorite

Prevalence of dyslipidaemia in statin-treated patients in Ireland: Irish results of the DYSlipidaemia International Study (DYSIS)

By Horgan S.  

Irish Journal of Medical Science, Vol. 180, Iss. 2, 2011-06 ,pp. : 343-349

Springer Publishing Company

Access to resources Recommend Favorite

Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis

By Mohiuddin Syed M.   Thakker Kamlesh M.   Setze Carolyn M.   Kelly Maureen T.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1067-1078

Informa Healthcare

Access to resources Recommend Favorite

Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients

By Derosa Giuseppe   Maffioli Pamela   Salvadeo Sibilla A. T.   Ferrari Ilaria   Gravina Alessia   Mereu Roberto   Palumbo Ilaria   D'angelo Angela   Cicero Arrigo F. G.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1973-1983

Informa Healthcare

Access to resources Recommend Favorite